VIP and colon carcinoma: Neuroendocrine peptides, such as vasoactive intestinal polypeptide (VIP), and calcitonin gene related peptide (CGRP), have been investigated in several studies in colon carcinoma patients and colon cancer experimental models and have been shown to be altered in neurons and nerve fibers [18, 19, 21, 22].